Drug Profile
BST 5001
Latest Information Update: 07 Apr 2004
Price :
$50
*
At a glance
- Originator BioStratum
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 07 Apr 2004 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 13 Feb 2001 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 27 Aug 1997 New profile